Product NDC: | 17478-069 |
Proprietary Name: | PANTOPRAZOLE SODIUM |
Non Proprietary Name: | PANTOPRAZOLE SODIUM |
Active Ingredient(s): | 40 mg/1 & nbsp; PANTOPRAZOLE SODIUM |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 17478-069 |
Labeler Name: | Akorn, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA079197 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121108 |
Package NDC: | 17478-069-14 |
Package Description: | 1 VIAL in 1 CARTON (17478-069-14) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
NDC Code | 17478-069-14 |
Proprietary Name | PANTOPRAZOLE SODIUM |
Package Description | 1 VIAL in 1 CARTON (17478-069-14) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
Product NDC | 17478-069 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | PANTOPRAZOLE SODIUM |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20121108 |
Marketing Category Name | ANDA |
Labeler Name | Akorn, Inc. |
Substance Name | PANTOPRAZOLE SODIUM |
Strength Number | 40 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |